Aspen Aerogels(ASPN)
$4.47-0.40 (-8.21%)
ASPN
Aspen Aerogels financials statements
$4.47
At close:-0.40 (-8.21%)
Want to see ASPN full AI Analyst Report?
Aspen Aerogels (ASPN) Ratios
1,240 Followers
Aspen Aerogels Ratios
ASPN's free cash flow for Q3 2026 was $-8.50M. For the 2026 fiscal year, ASPN's free cash flow was decreased by $-4.75M and operating cash flow was $-3.75M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.90 | 3.72 | 3.41 | 4.68 | 3.07 |
| Quick Ratio | 3.29 | 3.29 | 2.91 | 4.40 | 2.74 |
| Cash Ratio | 2.53 | 2.01 | 1.79 | 3.56 | 2.09 |
| Solvency Ratio | -2.01 | 0.13 | -0.13 | -0.38 | -0.51 |
| Operating Cash Flow Ratio | 0.53 | 0.41 | -0.55 | -1.20 | -0.51 |
| Short-Term Operating Cash Flow Coverage | 1.31 | 1.92 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 70.89M | $ 129.01M | $ 51.34M | $ 173.70M | $ 57.60M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.35 | 0.22 | 0.20 | 0.19 | 0.08 |
| Debt-to-Equity Ratio | 0.61 | 0.32 | 0.28 | 0.27 | 0.12 |
| Debt-to-Capital Ratio | 0.38 | 0.24 | 0.22 | 0.21 | 0.11 |
| Long-Term Debt-to-Capital Ratio | 0.25 | 0.18 | 0.19 | 0.19 | 0.00 |
| Financial Leverage Ratio | 1.73 | 1.46 | 1.44 | 1.44 | 1.42 |
| Debt Service Coverage Ratio | -9.31 | 1.39 | -4.19 | -13.39 | -119.76 |
| Interest Coverage Ratio | -4.80 | 4.56 | -9.23 | -15.51 | -177.29 |
| Debt to Market Cap | 0.45 | 0.17 | 0.10 | 0.22 | 0.00 |
| Interest Debt Per Share | 1.87 | 2.70 | 2.08 | 3.16 | 0.51 |
| Net Debt to EBITDA | 0.04 | -0.46 | 0.04 | 2.37 | 2.24 |
| Profitability Margins | |||||
| Gross Profit Margin | 16.97% | 40.40% | 23.84% | 2.76% | 8.17% |
| EBIT Margin | -138.86% | 5.97% | -16.96% | -43.04% | -30.31% |
| EBITDA Margin | -122.20% | 11.37% | -9.34% | -37.93% | -22.55% |
| Operating Profit Margin | -18.96% | 12.05% | -20.61% | -43.94% | -33.38% |
| Pretax Profit Margin | -142.81% | 3.33% | -19.19% | -45.87% | -30.50% |
| Net Profit Margin | -143.69% | 2.95% | -19.19% | -45.87% | -30.50% |
| Continuous Operations Profit Margin | -143.69% | 2.95% | -19.19% | -45.87% | -30.50% |
| Net Income Per EBT | 100.62% | 88.64% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 753.34% | 27.67% | 93.11% | 104.41% | 91.37% |
| Return on Assets (ROA) | -95.79% | 1.49% | -6.52% | -12.86% | -20.28% |
| Return on Equity (ROE) | -165.40% | 2.18% | -9.39% | -18.49% | -28.89% |
| Return on Capital Employed (ROCE) | -14.91% | 6.95% | -7.87% | -14.04% | -27.73% |
| Return on Invested Capital (ROIC) | -13.55% | 5.95% | -7.85% | -13.98% | -27.31% |
| Return on Tangible Assets | -95.79% | 1.49% | -6.52% | -12.86% | -20.28% |
| Earnings Yield | -166.52% | 1.45% | -4.18% | -17.83% | -2.45% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.69 | 4.15 | 3.41 | 3.14 | 5.95 |
| Payables Turnover | 17.00 | 6.08 | 3.56 | 3.20 | 6.40 |
| Inventory Turnover | 5.89 | 5.67 | 4.64 | 7.78 | 9.32 |
| Fixed Asset Turnover | 2.21 | 0.94 | 0.55 | 0.67 | 1.75 |
| Asset Turnover | 0.67 | 0.51 | 0.34 | 0.28 | 0.66 |
| Working Capital Turnover Ratio | 1.13 | 1.86 | 1.00 | 0.98 | 2.24 |
| Cash Conversion Cycle | 88.03 | 92.28 | 83.12 | 49.07 | 43.48 |
| Days of Sales Outstanding | 47.49 | 87.97 | 107.02 | 116.06 | 61.30 |
| Days of Inventory Outstanding | 62.02 | 64.33 | 78.68 | 46.90 | 39.17 |
| Days of Payables Outstanding | 21.47 | 60.01 | 102.58 | 113.89 | 57.00 |
| Operating Cycle | 109.51 | 152.30 | 185.70 | 162.96 | 100.48 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.40 | 0.59 | -0.61 | -2.40 | -0.61 |
| Free Cash Flow Per Share | -0.06 | -0.53 | -3.14 | -6.92 | -1.06 |
| Dividend Paid and CapEx Coverage Ratio | 0.88 | 0.53 | -0.24 | -0.53 | -1.35 |
| Capital Expenditure Coverage Ratio | 0.88 | 0.53 | -0.24 | -0.53 | -1.35 |
| Operating Cash Flow Coverage Ratio | 0.23 | 0.23 | -0.31 | -0.79 | -1.22 |
| Operating Cash Flow to Sales Ratio | 0.12 | 0.10 | -0.18 | -0.52 | -0.15 |
| Free Cash Flow Yield | -1.96% | -4.42% | -19.90% | -58.69% | -2.14% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.60 | 69.88 | -23.92 | -5.61 | -40.85 |
| Price-to-Sales (P/S) Ratio | 0.86 | 2.03 | 4.59 | 2.57 | 12.46 |
| Price-to-Book (P/B) Ratio | 0.99 | 1.50 | 2.25 | 1.04 | 11.80 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -51.11 | -22.62 | -5.02 | -1.70 | -46.76 |
| Price-to-Operating Cash Flow Ratio | 7.12 | 20.22 | -25.71 | -4.92 | -81.34 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | -0.56 | 0.34 | -0.04 | -0.39 |
| Enterprise Value Multiple | -0.67 | 17.44 | -49.08 | -4.42 | -53.02 |
| Enterprise Value | 220.78M | 897.62M | 1.09B | 302.16M | 1.45B |
| EV to EBITDA | -0.67 | 17.44 | -49.08 | -4.42 | -53.02 |
| EV to Sales | 0.81 | 1.98 | 4.59 | 1.68 | 11.95 |
| EV to Free Cash Flow | -48.24 | -22.05 | -5.02 | -1.11 | -44.87 |
| EV to Operating Cash Flow | 6.72 | 19.71 | -25.69 | -3.20 | -78.05 |
| Tangible Book Value Per Share | 2.85 | 7.93 | 7.03 | 11.37 | 4.22 |
| Shareholders’ Equity Per Share | 2.85 | 7.93 | 7.03 | 11.37 | 4.22 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.01 | 0.11 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 3.28 | 5.84 | 3.44 | 4.58 | 4.00 |
| Net Income Per Share | -4.71 | 0.17 | -0.66 | -2.10 | -1.22 |
| Tax Burden | 1.01 | 0.89 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.03 | 0.56 | 1.13 | 1.07 | 1.01 |
| Research & Development to Revenue | 0.05 | 0.04 | 0.07 | 0.09 | 0.09 |
| SG&A to Revenue | 0.31 | 0.24 | 0.24 | 0.21 | 0.19 |
| Stock-Based Compensation to Revenue | 0.03 | 0.03 | 0.00 | 0.05 | 0.04 |
| Income Quality | -0.08 | 3.41 | 0.93 | 1.14 | 0.50 |
Currency in USD

